DR. MARTHA M SKINNER, M.D.
Osteopathic Medicine in Boston, MA

License number
Massachusetts 29103
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
725 Albany Street Shapiro 7 SUITE B, Boston, MA 02118
Phone
(617) 638-7460
(617) 638-5226 (Fax)

Professional information

Martha M Skinner Photo 1

Dr. Martha M Skinner, Boston MA - MD (Doctor of Medicine)

Specialties:
Rheumatology
Address:
715 Albany St STE 501, Boston 02118
(617) 638-7460 (Phone)
Boston Medical Center-RHU
725 Albany St STE 7B, Boston 02118
(617) 638-7460 (Phone)
720 Harrison Ave STE 401, Boston 02118
(617) 638-7460 (Phone)
Conditions:
Amyloidosis
Languages:
English, Spanish
Hospitals:
715 Albany St STE 501, Boston 02118
720 Harrison Ave STE 401, Boston 02118
Boston Medical Center-RHU
725 Albany St STE 7B, Boston 02118
Boston Medical Center Corporation
1 Boston Medical Ctr Pl, Boston 02118
Education:
Medical School
Medical College Of Pennsylvania
Graduated: 1962
New England Deaconess Hospital


Martha Skinner Photo 2

Human Prealbumin And Related Methods And Products

US Patent:
4816388, Mar 28, 1989
Filed:
Oct 30, 1985
Appl. No.:
6/792817
Inventors:
Jean D. Sipe - Roslindale MA
Alexander S. Whitehead - Needham MA
Alan S. Cohen - Newton MA
Martha Skinner - Chestnut Hill MA
Assignee:
Children's Medical Center Corporation - Boston MA
International Classification:
C12Q 168, C07H 1512, C12N 1500
US Classification:
435 6
Abstract:
Recombinant human prealbumin and a method for producing such human prealbumin through recombinant DNA techniques including preparation and isolation of a cDNA sequence coding for human prealbumin, construction of a cloning vector and an expression vector containing said cDNA sequence, and expression of human prealbumin in a prokaryotic cell transformed by said expression vector are disclosed. The invention further relates to the use of human prealbumin cDNA in the diagnosis by hybridization methodologies of medical conditions with which variant forms of prealbumin are associated. Also disclosed is a method for diagnosing some Type I familial amyloid polyneuropathies by a restriction endonuclease assay with an enzyme which recognizes the nucleotide base sequence 5'-ATGCAT-3'.